CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total	COMMON STOCK	ADDITIONAL PAID-IN CAPITAL	RETAINED EARNINGS	ACCUMULATED OTHER COMPREHENSIVE LOSS	TREASURY SHARES	NON-CONTROLLING INTERESTS
Balance, beginning of period at Dec. 31, 2022		$ 561	$ 1,179	$ 20,301	$ (5,314)	$ (6,207)	$ 229
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			(101)
Issuance of shares under stock compensation plans and employee stock purchase plans			66			208
Purchase of non-controlling interest			(70)
Net income attributable to the Company	$ 2,299			2,270			29
Dividend equivalents declared				(8)
Dividends declared				(583)
Other comprehensive (loss) income, net of tax	259				259
Purchase of treasury shares	(600)					(600)
Net non-controlling interests acquired							(69)
Distributions and other changes							(11)
Balance, end of period at Jun. 30, 2023	$ 12,139		1,074	21,980	(5,055)	(6,599)	178
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 1.18
Balance, beginning of period at Mar. 31, 2023		561	1,064	20,949	(5,234)	(6,387)	243
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			89
Issuance of shares under stock compensation plans and employee stock purchase plans			(9)			88
Purchase of non-controlling interest			(70)
Net income attributable to the Company	$ 1,047			1,035			12
Dividend equivalents declared				(4)
Dividends declared				0
Other comprehensive (loss) income, net of tax	179				179
Purchase of treasury shares						(300)
Net non-controlling interests acquired							(69)
Distributions and other changes							(8)
Balance, end of period at Jun. 30, 2023	$ 12,139		1,074	21,980	(5,055)	(6,599)	178
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 0
Balance, beginning of period at Dec. 31, 2023	$ 12,370	561	1,242	22,759	(5,295)	(7,076)	179
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			(125)
Issuance of shares under stock compensation plans and employee stock purchase plans			80			234
Purchase of non-controlling interest			0
Net income attributable to the Company	2,564			2,525			39
Dividend equivalents declared				(7)
Dividends declared				(699)
Other comprehensive (loss) income, net of tax	(232)				(232)
Purchase of treasury shares	(600)					(600)
Net non-controlling interests acquired							0
Distributions and other changes							(20)
Balance, end of period at Jun. 30, 2024	$ 13,565		1,197	24,578	(5,527)	(7,442)	198
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 1.42
Balance, beginning of period at Mar. 31, 2024		$ 561	1,112	23,456	(5,509)	(7,198)	200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			80
Issuance of shares under stock compensation plans and employee stock purchase plans			5			56
Purchase of non-controlling interest			0
Net income attributable to the Company	$ 1,140			1,125			15
Dividend equivalents declared				(2)
Dividends declared				(1)
Other comprehensive (loss) income, net of tax	(18)				(18)
Purchase of treasury shares						(300)
Net non-controlling interests acquired							0
Distributions and other changes							(17)
Balance, end of period at Jun. 30, 2024	$ 13,565		$ 1,197	$ 24,578	$ (5,527)	$ (7,442)	$ 198
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 0